Marrone Bio Innovations Company Profile (NASDAQ:MBII)

About Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations logoMarrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $30.48 million
  • Outstanding Shares: 24,778,000
Average Prices:
  • 50 Day Moving Avg: $1.59
  • 200 Day Moving Avg: $2.03
  • 52 Week Range: $0.62 - $2.79
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.86
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $15.53 million
  • Price / Sales: 1.96
  • Book Value: ($1.50) per share
  • Price / Book: -0.82
Profitability:
  • EBIDTA: ($19,960,000.00)
  • Net Margins: -258.51%
  • Return on Assets: -56.17%
Debt:
  • Debt-to-Equity Ratio: -2.48%
  • Current Ratio: 2.44%
  • Quick Ratio: 1.77%
Misc:
  • Average Volume: 78,965 shs.
  • Beta: 0.46
  • Short Ratio: 35.84
 

Frequently Asked Questions for Marrone Bio Innovations (NASDAQ:MBII)

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations Inc (NASDAQ:MBII) issued its earnings results on Wednesday, March, 29th. The company reported ($0.32) EPS for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.06. The firm had revenue of $2.69 million for the quarter. View Marrone Bio Innovations' Earnings History.

Where is Marrone Bio Innovations' stock going? Where will Marrone Bio Innovations' stock price be in 2017?

2 equities research analysts have issued 1 year price targets for Marrone Bio Innovations' shares. Their forecasts range from $2.50 to $2.50. On average, they expect Marrone Bio Innovations' stock price to reach $2.50 in the next year. View Analyst Ratings for Marrone Bio Innovations.

Are investors shorting Marrone Bio Innovations?

Marrone Bio Innovations saw a increase in short interest in May. As of May 15th, there was short interest totalling 841,670 shares, an increase of 4.0% from the April 28th total of 809,058 shares. Based on an average daily trading volume, of 107,954 shares, the days-to-cover ratio is currently 7.8 days.

Who are some of Marrone Bio Innovations' key competitors?

Who owns Marrone Bio Innovations stock?

Marrone Bio Innovations' stock is owned by a number of of retail and institutional investors. Top institutional investors include Primecap Management Co. CA (10.98%), Vanguard Group Inc. (1.38%), Geode Capital Management LLC (0.30%) and Spark Investment Management LLC (0.25%). Company insiders that own Marrone Bio Innovations stock include Ardsley Advisory Partners, George H Kerckhove, James Boyd, Pamela G Marrone, Richard E Rominger and Timothy B Johnson. View Institutional Ownership Trends for Marrone Bio Innovations.

Who sold Marrone Bio Innovations stock? Who is selling Marrone Bio Innovations stock?

Marrone Bio Innovations' stock was sold by a variety of institutional investors in the last quarter, including Primecap Management Co. CA and Spark Investment Management LLC. View Insider Buying and Selling for Marrone Bio Innovations.

Who bought Marrone Bio Innovations stock? Who is buying Marrone Bio Innovations stock?

Marrone Bio Innovations' stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc.. Company insiders that have bought Marrone Bio Innovations stock in the last two years include Ardsley Advisory Partners, George H Kerckhove, James Boyd, Pamela G Marrone, Richard E Rominger and Timothy B Johnson. View Insider Buying and Selling for Marrone Bio Innovations.

How do I buy Marrone Bio Innovations stock?

Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Marrone Bio Innovations stock cost?

One share of Marrone Bio Innovations stock can currently be purchased for approximately $1.23.

Analyst Ratings

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.50 (103.25% upside)

Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017HC WainwrightReiterated RatingBuyHighView Rating Details
5/2/2017Jefferies Group LLCReiterated RatingHold$2.50LowView Rating Details
5/14/2016Piper Jaffray CompaniesReiterated RatingOverweight$2.00 -> $1.00N/AView Rating Details
3/16/2016Rodman & RenshawInitiated CoverageBuy$3.50N/AView Rating Details
12/31/2015Roth CapitalReiterated RatingBuy -> Not Rated$15.00N/AView Rating Details
(Data available from 5/26/2015 forward)

Earnings

Earnings History for Marrone Bio Innovations (NASDAQ:MBII)
Earnings by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Earnings History by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/29/2017Q4 2016($0.26)($0.32)$2.69 millionViewN/AView Earnings Details
11/14/2016Q316($0.22)($0.29)$4.61 million$3.63 millionViewN/AView Earnings Details
8/9/2016Q216($0.28)($0.28)$4.61 million$5.00 millionViewN/AView Earnings Details
5/12/2016Q116($0.27)($0.38)$3.05 million$2.70 millionViewListenView Earnings Details
3/30/2016Q215($0.40)($0.45)$1.10 million$1.90 millionViewListenView Earnings Details
8/7/2014Q2 2014($0.49)($0.50)$7.59 million$3.63 millionViewN/AView Earnings Details
5/13/2014Q114($0.37)($0.52)$4.63 million$2.80 millionViewN/AView Earnings Details
3/6/2014Q4 2013($0.40)($0.52)$5.80 million$5.97 millionViewN/AView Earnings Details
9/12/2013Q2 2013($0.33)($2.36)$4.33 million$4.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Marrone Bio Innovations (NASDAQ:MBII)
Current Year EPS Consensus Estimate: $-0.92 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS

Dividends

Dividend History for Marrone Bio Innovations (NASDAQ:MBII)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Marrone Bio Innovations (NASDAQ:MBII)
Insider Ownership Percentage: 7.25%
Institutional Ownership Percentage: 37.95%
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Institutional Ownership by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/28/2017Ardsley Advisory PartnersMajor ShareholderSell1,189,700$1.68$1,998,696.00View SEC Filing  
4/25/2017Ardsley Advisory PartnersMajor ShareholderBuy50,000$1.72$86,000.00View SEC Filing  
6/15/2016Richard E RomingerDirectorBuy10,000$0.94$9,400.00View SEC Filing  
6/13/2016James BoydCFOBuy10,000$0.79$7,900.00View SEC Filing  
6/9/2016George H KerckhoveDirectorBuy2,500$0.72$1,800.00View SEC Filing  
6/9/2016Pamela G MarroneCEOBuy5,000$0.72$3,600.00View SEC Filing  
6/9/2016Timothy B JohnsonVPBuy10,000$0.72$7,200.00View SEC Filing  
8/14/2014George H KerckhoveDirectorBuy400$5.90$2,360.00View SEC Filing  
8/12/2014Pamela G MarroneCEOBuy1,000$5.29$5,290.00View SEC Filing  
2/12/2014Ventures Pte. Ltd. Syngentamajor shareholderSell332,027$14.72$4,887,437.44View SEC Filing  
1/29/2014Donald GlidewellCFOSell75,495$17.00$1,283,415.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Marrone Bio Innovations (NASDAQ:MBII)
Latest Headlines for Marrone Bio Innovations (NASDAQ:MBII)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Marrone Bio Innovations, Inc. : May 25, 2017
finance.yahoo.com - May 26 at 3:44 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Short Interest Update
www.americanbankingnews.com - May 25 at 11:06 AM
finance.yahoo.com logoMarrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 10:54 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - May 19 at 12:08 AM
zacks.com logoMarrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y
www.zacks.com - May 15 at 10:32 AM
finance.yahoo.com logoMarrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y
finance.yahoo.com - May 15 at 10:32 AM
americanbankingnews.com logoHC Wainwright Reiterates "Buy" Rating for Marrone Bio Innovations Inc (MBII)
www.americanbankingnews.com - May 13 at 9:04 AM
reuters.com logoBRIEF-Marrone Bio Innovations inks deal with Jet Harvest Solutions
www.reuters.com - May 12 at 1:58 AM
seekingalpha.com logoMarrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 1:58 AM
finance.yahoo.com logoMarrone Bio Innovations Enters into Master Distribution Agreement with Jet Harvest Solutions
finance.yahoo.com - May 11 at 6:57 PM
finance.yahoo.com logoInvestor Network: Marrone Bio Innovations, Inc. to Host Earnings Call
finance.yahoo.com - May 11 at 6:57 PM
finance.yahoo.com logoMarrone Bio Innovations, Inc. Reports 2017 First Quarter Results
finance.yahoo.com - May 11 at 6:57 PM
finance.yahoo.com logo5 things to know, and photos from Mikuni's big anniversary party
finance.yahoo.com - May 10 at 5:59 PM
finance.yahoo.com logoAgri-Star and Marrone Bio Innovations Sign Exclusive Distribution Agreement to Distribute Grandevo and Venerate Bioinsecticides for Mexico
finance.yahoo.com - May 9 at 11:54 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Expected to Post Earnings of -$0.31 Per Share
www.americanbankingnews.com - May 9 at 10:07 AM
finance.yahoo.com logoMarrone Bio Innovations’ Bioinsecticides Help Fruit Growers Combat the Invasive Pest, Spotted Wing Drosophila
finance.yahoo.com - May 4 at 11:46 AM
finance.yahoo.com logoMarrone Bio Innovations Announces Date for First Quarter 2017 Financial Results
finance.yahoo.com - May 4 at 11:46 AM
americanbankingnews.com logoPositive Media Coverage Somewhat Likely to Affect Marrone Bio Innovations (MBII) Share Price
www.americanbankingnews.com - May 3 at 12:46 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Rating Reiterated by Jefferies Group LLC
www.americanbankingnews.com - May 2 at 11:46 PM
americanbankingnews.com logoArdsley Advisory Partners Sells 1,189,700 Shares of Marrone Bio Innovations Inc (MBII) Stock
www.americanbankingnews.com - May 1 at 9:42 PM
americanbankingnews.com logoMarrone Bio Innovations (MBII) Given Media Sentiment Rating of 0.19
www.americanbankingnews.com - April 30 at 12:23 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Major Shareholder Ardsley Advisory Partners Purchases 50,000 Shares
www.americanbankingnews.com - April 29 at 1:23 AM
finance.yahoo.com logoMarrone Bio Innovations, Inc. Closes $9.2 Million Public Offering of Common Stock with Full Exercise of over-Allotment Option
finance.yahoo.com - April 28 at 7:20 PM
reuters.com logoBRIEF-Marrone Bio Innovations says offering of 5.71 mln common shares priced at $1.40/share
www.reuters.com - April 26 at 6:54 PM
americanbankingnews.com logoMarrone Bio Innovations (MBII) Earning Somewhat Positive Press Coverage, Report Finds
www.americanbankingnews.com - April 25 at 9:18 PM
streetinsider.com logoUPDATE: Marrone Bio (MBII) Prices 5.71M Common Stock Offering at $1.40/Share
www.streetinsider.com - April 25 at 5:48 PM
bizjournals.com logoMarrone Bio raising $8 million with stock offering
www.bizjournals.com - April 25 at 5:48 PM
finance.yahoo.com logoMarrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering
finance.yahoo.com - April 25 at 5:48 PM
finance.yahoo.com logoETFs with exposure to Marrone Bio Innovations, Inc. : April 25, 2017
finance.yahoo.com - April 25 at 5:48 PM
reuters.com logoBRIEF-Marrone Bio Innovations reports proposed public offering of common stock
www.reuters.com - April 24 at 7:16 PM
finance.yahoo.com logoMarrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - April 24 at 7:16 PM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Expected to Announce Earnings of -$0.31 Per Share
www.americanbankingnews.com - April 18 at 3:01 PM
americanbankingnews.com logoSomewhat Favorable Press Coverage Unlikely to Affect Marrone Bio Innovations (MBII) Stock Price
www.americanbankingnews.com - April 17 at 7:51 PM
finance.yahoo.com logoMarrone Bio Innovations and Center for Land-Based Learning Collaborate to Present Marrone Bio Cannery Farm ... - Yahoo Finance
finance.yahoo.com - April 12 at 5:47 AM
finance.yahoo.com logoMarrone Bio Innovations and Center for Land-Based Learning Collaborate to Present Marrone Bio Cannery Farm Volunteer Day
finance.yahoo.com - April 11 at 6:23 PM
businesswire.com logoMarrone Bio Innovations to Hold Webinar on Insect Pest Management in Walnuts - Business Wire (press release)
www.businesswire.com - April 8 at 6:22 AM
finance.yahoo.com logoETFs with exposure to Marrone Bio Innovations, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 6:55 PM
finance.yahoo.com logoMarrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
finance.yahoo.com - April 7 at 11:04 AM
finance.yahoo.com logoMarrone Bio Innovations to Hold Webinar on Insect Pest Management in Walnuts
finance.yahoo.com - April 7 at 11:04 AM
biz.yahoo.com logoMARRONE BIO INNOVATIONS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - April 4 at 8:56 AM
biz.yahoo.com logoMARRONE BIO INNOVATIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
biz.yahoo.com - March 31 at 6:29 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-Lululemon, ConocoPhillips, Cenovus, Stage Stores, VF Corp, Stage Stores - Nasdaq
www.nasdaq.com - March 31 at 9:43 AM
reuters.com logoBRIEF-Marrone Bio Innovations entered into invoice purchase agreement with LSQ Funding Group
www.reuters.com - March 30 at 6:46 PM
biz.yahoo.com logoMARRONE BIO INNOVATIONS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - March 30 at 6:46 PM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS
www.americanbankingnews.com - March 30 at 8:59 AM
reuters.com logoBRIEF-Marrone Bio Innovations Q4 loss per share $ 0.32
www.reuters.com - March 29 at 7:02 PM
finance.yahoo.com logoMarrone Bio Innovations Reports Fourth Quarter and Record Full Year 2016 Results
finance.yahoo.com - March 29 at 7:02 PM
biz.yahoo.com logoQ4 2016 Marrone Bio Innovations Inc Earnings Release - After Market Close
biz.yahoo.com - March 29 at 10:02 AM
finance.yahoo.com logoMarrone Bio Innovations and Evogene Advance Novel Bacteria and Related Proteins Beyond Discovery into Insecticidal Product Development Phase
finance.yahoo.com - March 28 at 10:34 AM
americanbankingnews.com logoMarrone Bio Innovations Inc (MBII) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - March 28 at 7:44 AM

Social

Chart

Marrone Bio Innovations (MBII) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff